» Articles » PMID: 33484493

Kv1.1 Deficiency Alters Repetitive and Social Behaviors in Mice and Rescues Autistic-like Behaviors Due to Scn2a Haploinsufficiency

Overview
Journal Brain Behav
Specialty Psychology
Date 2021 Jan 23
PMID 33484493
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autism spectrum disorder (ASD) and epilepsy are highly comorbid, suggesting potential overlap in genetic etiology, pathophysiology, and neurodevelopmental abnormalities; however, the nature of this relationship remains unclear. This work investigated how two ion channel mutations, one associated with autism (Scn2a-null) and one with epilepsy (Kcna1-null), interact to modify genotype-phenotype relationships in the context of autism. Previous studies have shown that Scn2a ameliorates epilepsy in Kcna1 mice, improving survival, seizure characteristics, and brain-heart dynamics. Here, we tested the converse, whether Kcna1 deletion modifies ASD-like repetitive and social behaviors in Scn2a mice.

Methods: Mice were bred with various combinations of Kcna1 and Scn2a knockout alleles. Animals were assessed for repetitive behaviors using marble burying, grooming, and nestlet shredding tests and for social behaviors using sociability and social novelty preference tests.

Results: Behavioral testing revealed drastic reductions in all repetitive behaviors in epileptic Kcna1 mice, but relatively normal social interactions. In contrast, mice with partial Kcna1 deletion (Kcna1 ) exhibited increased self-grooming and decreased sociability suggestive of ASD-like features similar to those observed in Scn2a mice. In double-mutant Scn2a ; Kcna1 mice, the two mutations interacted to partially normalize ASD-like behaviors associated with each mutation independently.

Conclusions: Taken together, these findings suggest that Kv1.1 subunits are important in pathways and neural networks underlying ASD and that Kcna1 may be a therapeutic target for treatment of Scn2a-associated ASD.

Citing Articles

Deciphering : A comprehensive review of rodent models of dysfunction.

Scott K, Hermosillo Arrieta M, Williams A ArXiv. 2024; .

PMID: 39606727 PMC: 11601800.


Visual and auditory attention in individuals with DYRK1A and SCN2A disruptive variants.

Hudac C, Dommer K, Mahony M, DesChamps T, Cairney B, Earl R Autism Res. 2024; .

PMID: 39080977 PMC: 11779982. DOI: 10.1002/aur.3202.


Shared behavioural impairments in visual perception and place avoidance across different autism models are driven by periaqueductal grey hypoexcitability in Setd5 haploinsufficient mice.

Burnett L, Koppensteiner P, Symonova O, Masson T, Vega-Zuniga T, Contreras X PLoS Biol. 2024; 22(6):e3002668.

PMID: 38857283 PMC: 11216578. DOI: 10.1371/journal.pbio.3002668.


Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in Scn2aK1422E mice.

Echevarria-Cooper D, Hawkins N, Misra S, Huffman A, Thaxton T, Thompson C Hum Mol Genet. 2022; 31(17):2964-2988.

PMID: 35417922 PMC: 9433730. DOI: 10.1093/hmg/ddac087.


A Novel Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine.

Imbrici P, Conte E, Blunck R, Stregapede F, Liantonio A, Tosi M Int J Mol Sci. 2021; 22(18).

PMID: 34576077 PMC: 8469797. DOI: 10.3390/ijms22189913.


References
1.
Silverman J, Tolu S, Barkan C, Crawley J . Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP. Neuropsychopharmacology. 2009; 35(4):976-89. PMC: 2827881. DOI: 10.1038/npp.2009.201. View

2.
Fatemi S, Aldinger K, Ashwood P, Bauman M, Blaha C, Blatt G . Consensus paper: pathological role of the cerebellum in autism. Cerebellum. 2012; 11(3):777-807. PMC: 3677555. DOI: 10.1007/s12311-012-0355-9. View

3.
Fisher B, Dezort C, Nordli D, Berg A . Routine developmental and autism screening in an epilepsy care setting. Epilepsy Behav. 2012; 24(4):488-92. DOI: 10.1016/j.yebeh.2012.06.006. View

4.
Spooren W, Lindemann L, Ghosh A, Santarelli L . Synapse dysfunction in autism: a molecular medicine approach to drug discovery in neurodevelopmental disorders. Trends Pharmacol Sci. 2012; 33(12):669-84. DOI: 10.1016/j.tips.2012.09.004. View

5.
Lorincz A, Nusser Z . Cell-type-dependent molecular composition of the axon initial segment. J Neurosci. 2009; 28(53):14329-40. PMC: 2628579. DOI: 10.1523/JNEUROSCI.4833-08.2008. View